Back to CVE records
Medium 6.9Published Aug 18, 2026

CVE-2026-54570AngleSharp: HTML5 Spec Compliance: mXSS via annotation-xml HTML Integration Point Bypass

Updated under an hour ago ()

Does this affect you?

It affects AngleSharp. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

AngleSharp is a .NET library for parsing angle bracket based hyper-texts. Prior to 1.5.0, MathAnnotationXmlElement in AngleSharp/Mathml/Dom/Internal/MathAnnotationXmlElement.cs is not treated as an HTML integration point when its encoding attribute is text/html or application/xhtml+xml, causing Consume in AngleSharp/Html/Parser/HtmlDomBuilder.cs to route tokens through foreign-content parsing instead of HTML parsing. A sanitizer can therefore observe a different DOM from the browser that reparses the serialized output. An attacker can combine this namespace differential with markup-breaking characters in an attribute value so that an element hidden from the sanitizer becomes active script-capable HTML after browser reparse, resulting in mutation cross-site scripting. This issue is fixed in version 1.5.0.

CVSS
6.9 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:C/C:L/I:H/A:N
Weakness (CWE)
CWE-80
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
Aug 18, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
AngleSharp AngleSharp
anglesharp:anglesharp (from the name)
before 1.5.0
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.